Oxford Biomedica plc announced that, after more than 13 years of service, John Dawson, Chief Executive Officer, has signalled to the Board his intention to retire from the company.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
348.8 GBX | +2.57% | +0.44% | +56.82% |
07-17 | Oxford Biomedica plc Announces Board Changes, Effective from September 2, 2024 | CI |
07-17 | Oxford Biomedica Names New Finance Chief | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.82% | 466M | |
+20.03% | 126B | |
+23.61% | 117B | |
+22.88% | 27.52B | |
-18.07% | 20.87B | |
-13.85% | 17.01B | |
-14.81% | 16.26B | |
+9.78% | 14.56B | |
-46.10% | 15.09B | |
+52.34% | 13.89B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford Biomedica plc Announces Retirement of John Dawson as Chief Executive Officer